Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Correction: Antibody–Peptide Epitope Conjugates for Personalized Cancer Therapy

Songfa Zhang, Chuan Yan, David G. Millar, Qiqi Yang, James M. Heather, Adam Langenbucher, Laura T. Morton, Sean Sepulveda, Eric Alpert, Lauren R. Whelton, Dominique T. Zarrella, Mei Guo, Eleanor Minogue, Michael S. Lawrence, Bo R. Rueda, David R. Spriggs, Weiguo Lu, David M. Langenau, Mark Cobbold

Cancer Res (2024) 84 (9): 1534.

https://doi.org/10.1158/0008-5472.CAN-24-0718

Published: 02 May 2024

View article titled, Correction: Antibody–Peptide Epitope Conjugates for Personalized Cancer Therapy

Journal Articles

Abstract 7557: Hypoxia-induced downregulation of MUC16: A key player in bispecific T-cell engager resistance in ovarian cancer

Mengyao Xu, Syem K. Barakzai, Artem Kononenko, Raj Kumar, Irva Veillard, Eugene Kim, Timothy S. Bond, David R. Spriggs, Bo R. Rueda, Oladapo Yeku

Cancer Res (2024) 84 (6_Supplement): 7557.

https://doi.org/10.1158/1538-7445.AM2024-7557

Published: 22 March 2024

View article titled, Abstract 7557: Hypoxia-induced downregulation of MUC16: A key player in bispecific T-cell engager resistance in ovarian cancer

Journal Articles

Abstract A104: Losartan rewires ovarian cancer tumor-immune microenvironment and suppresses IGF-1 to amplify chemo-immunotherapy sensitivity

Yao Sun, Zhenzhen Yin, Limeng Wu, Changli Yue, Sonu Subudhi, Pinji Lei, Alona Muzikansky, Bo R. Rueda, Lei Xu

Cancer Res (2024) 84 (5_Supplement_2): A104.

https://doi.org/10.1158/1538-7445.OVARIAN23-A104

Published: 04 March 2024

View article titled, Abstract A104: Losartan rewires ovarian cancer tumor-immune microenvironment and suppresses IGF-1 to amplify chemo-immunotherapy sensitivity

Journal Articles

Abstract A113: Extracellular vesicles derived from enriched ovarian cancer stem cell fractions promote stem like properties in the more vulnerable tumor cell populations

Venkatesh Pooladanda, Shaan Kumar, Yusuke Matoba, Maryam Azimi Mohammadabadi, Dominique T. Zarrella, Ursula A. Winter, Sarah J. Hill, Hyungsoon Im, Bo R. Rueda

Cancer Res (2024) 84 (5_Supplement_2): A113.

https://doi.org/10.1158/1538-7445.OVARIAN23-A113

Published: 04 March 2024

View article titled, Abstract A113: Extracellular vesicles derived from enriched ovarian cancer stem cell fractions promote stem like properties in the more vulnerable tumor cell populations

Journal Articles

Abstract 5731: Apoptosis Inducing Agent 1 enhances cancer therapy-induced apoptosis by direct interaction with BAX and BAK

Xingping Qin, Cameron Fraser, Adam Presser, Johan KE Spetz, Stacey J. Yu, Gary A. Bradshaw, Marian Kalocsay, Bo R. Rueda, Tudor Moldoveanu, Kristopher A. Sarosiek

Cancer Res (2023) 83 (7_Supplement): 5731.

https://doi.org/10.1158/1538-7445.AM2023-5731

Published: 04 April 2023

View article titled, Abstract 5731: Apoptosis Inducing Agent 1 enhances cancer therapy-induced apoptosis by direct interaction with BAX and BAK

Journal Articles

Abstract 2438: Loss of galectin 3 reveals its potential roles in the aggressive pathology of uterine serous carcinoma

Yusuke Matoba, Dominique T. Zarrella, Venkatesh Pooladanda, Eugene Kim, Shaan Kumar, Mengyao Xu, Xingping Qin, Raj Kumar, Artem Kononenko, Irva Veillard, Kristopher Sarosiek, Oladapo Yeku, David R. Spriggs, Bo R. Rueda

Cancer Res (2023) 83 (7_Supplement): 2438.

https://doi.org/10.1158/1538-7445.AM2023-2438

Published: 04 April 2023

View article titled, Abstract 2438: Loss of galectin 3 reveals its potential roles in the aggressive pathology of uterine serous carcinoma

Journal Articles

Abstract 3390: Preliminary results for a novel single extracellular vesicle assay for early stage ovarian cancer: The power of co-localized detection of surface biomarkers

Laura T. Bortolin, Daniel P. Salem, Sanchari Banerjee, Kelly M. Biette, Delaney M. Byrne, Anthony D. Couvillon, Peter A. Duff, Jonian Grosha, MacKenzie Sadie King, Christopher R. Sedlak, Ibukunoluwapo O. Zabroski, Claire Alexander, Karen Copeland, Daniel Gusenleitner, Emily S. Winn-Deen, Eric K. Huang, Bo R. Rueda, Joseph Charles Sedlak

Cancer Res (2022) 82 (12_Supplement): 3390.

https://doi.org/10.1158/1538-7445.AM2022-3390

Published: 15 June 2022

View article titled, Abstract 3390: Preliminary results for a novel single extracellular vesicle assay for early stage ovarian cancer: The power of co-localized detection of surface biomarkers

Journal Articles

Antibody-Peptide Epitope Conjugates for Personalized Cancer Therapy

Cancer Res (2022) 82 (5): 773–784.

https://doi.org/10.1158/0008-5472.CAN-21-2200

Published: 01 March 2022

View article titled, Antibody-Peptide Epitope Conjugates for Personalized Cancer Therapy

Includes: Supplementary data

Journal Articles

Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer

Cancer Res (2021) 81 (1): 158–173.

https://doi.org/10.1158/0008-5472.CAN-20-1674

Published: 04 January 2021

View article titled, Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer

Includes: Supplementary data

Journal Articles

Abstract LB-229: Utilizing a novel highly specific sialyl-Tn ELISA as a diagnostic for ovarian cancer

Linah F. Al-Alem, Jillian Prendergast, Justin Clark, Bianca Zarrella, Dan Dransfield, Whitfield Growdon, David Spriggs, Eric Eisenhauer, Jeff Behrens, Bo R. Rueda

Cancer Res (2019) 79 (13_Supplement): LB-229.

https://doi.org/10.1158/1538-7445.AM2019-LB-229

Published: 01 July 2019

View article titled, Abstract LB-229: Utilizing a novel highly specific sialyl-Tn ELISA as a diagnostic for ovarian cancer

Journal Articles

Abstract 2504: Assessing the efficacy of the anti metabolic drug, CPI-613, for targeting of ovarian cancer stem cells

Chiara Bellio, Rosemary Foster, Whitfield B. Growdon, Bo R. Rueda

Cancer Res (2016) 76 (14_Supplement): 2504.

https://doi.org/10.1158/1538-7445.AM2016-2504

Published: 15 July 2016

View article titled, Abstract 2504: Assessing the efficacy of the anti metabolic drug, CPI-613, for targeting of ovarian cancer stem cells

Journal Articles

Abstract 386: Addition of mTOR inhibition to HER2 blockade results in improved antitumor activity in a preclinical model of uterine serous carcinoma with HER2 gene amplification and a gain of function mutation in PIK3CA

Silvia F. Hernandez, Sarah Chisholm, Darrell Borger, Rosemary Foster, Bo R. Rueda, Whitfield B. Growdon

Cancer Res (2016) 76 (14_Supplement): 386.

https://doi.org/10.1158/1538-7445.AM2016-386

Published: 15 July 2016

View article titled, Abstract 386: Addition of mTOR inhibition to HER2 blockade results in improved antitumor activity in a preclinical model of uterine serous carcinoma with HER2 gene amplification and a gain of function mutation in PIK3CA

Journal Articles

Abstract 3410: Inhibitors of Skp2 E3ligase stabilize nuclear p27^kip1 for regain of growth regulation in cancer.

Savvas C. Pavlides, Kuang-Tzu Huang, Lily Wu, Bo R. Rueda, Stephanie V. Blank, Khushbakhat R. Mittal, Timothy Cardozo, Leslie I. Gold

Cancer Res (2013) 73 (8_Supplement): 3410.

https://doi.org/10.1158/1538-7445.AM2013-3410

Published: 15 April 2013

View article titled, Abstract 3410: Inhibitors of Skp2 E3ligase stabilize nuclear p27kip1 for regain of growth regulation in cancer.

Journal Articles

Abstract 3285: Hedgehog pathway inhibition delays regrowth of ovarian cancer following paclitaxel and carboplatinum only if initiated immediately after completion of chemotherapy

Kashmira S. Kulkarni-Datar, Whitfield B. Growdon, Jeanne A. Ferguson, John R. MacDougall, Rosemary Foster, Bo R. Rueda

Cancer Res (2012) 72 (8_Supplement): 3285.

https://doi.org/10.1158/1538-7445.AM2012-3285

Published: 15 April 2012

View article titled, Abstract 3285: Hedgehog pathway inhibition delays regrowth of ovarian cancer following paclitaxel and carboplatinum only if initiated immediately after completion of chemotherapy

Journal Articles

Abstract 3474: Ovarian cancer tumor initiating cells persist after paclitaxel and carboplatinum treatment in vivo

Kashmira S. Kulkarni-Datar, Sandra Orsulic, Rosemary Foster, Bo R. Rueda

Cancer Res (2012) 72 (8_Supplement): 3474.

https://doi.org/10.1158/1538-7445.AM2012-3474

Published: 15 April 2012

View article titled, Abstract 3474: Ovarian cancer tumor initiating cells persist after paclitaxel and carboplatinum treatment in vivo

Journal Articles

Abstract 4556: Epidermal growth factor signaling alterations in uterine papillary serous carcinoma (UPSC) associate with survival

Jolijn W. Groeneweg, Rosemary H. Tambouret, Darrell R. Borger, Rosemary Foster, Bo R. Rueda, Whitfield B. Growdon

Cancer Res (2012) 72 (8_Supplement): 4556.

https://doi.org/10.1158/1538-7445.AM2012-4556

Published: 15 April 2012

View article titled, Abstract 4556: Epidermal growth factor signaling alterations in uterine papillary serous carcinoma (UPSC) associate with survival

Journal Articles

BRCA1-Associated Epigenetic Regulation of p73 Mediates an Effector Pathway for Chemosensitivity in Ovarian Carcinoma

Nageatte Ibrahim, Lei He, Chee-Onn Leong, Deyin Xing, Beth Y. Karlan, Elizabeth M. Swisher, Bo R. Rueda, Sandra Orsulic, Leif W. Ellisen

Cancer Res (2010) 70 (18): 7155–7165.

https://doi.org/10.1158/0008-5472.CAN-10-0668

Published: 14 September 2010

View article titled, BRCA1-Associated Epigenetic Regulation of p73 Mediates an Effector Pathway for Chemosensitivity in Ovarian Carcinoma

Includes: Supplementary data

Journal Articles

Abstract 4302: Human endometrial cancer cell CD133⁺ cell fractions are regulated by methylation

Bo R. Rueda, Anne M. Friel, Ling Zhang, Michael D. Curley, Gayatry Mohapatra, Petra A. Sergent, Vanessa A. Therrien, Rosemary Foster

Cancer Res (2010) 70 (8_Supplement): 4302.

https://doi.org/10.1158/1538-7445.AM10-4302

Published: 15 April 2010

View article titled, Abstract 4302: Human endometrial cancer cell CD133+ cell fractions are regulated by methylation

Journal Articles

Abstract LB-51: Correlation of expression of MDR-associated genes with outcome in primary ovarian serous carcinoma

Jean-Pierre Gillet, Anna Maria Calcagno, Sudhir Varma, Ben Davidson, Mari Bunkholt Elstrand, Ram Ganapathi, Anil K. Sood, Suresh V. Ambudkar, Michael V. Seiden, Bo R. Rueda, Michael M. Gottesman

Cancer Res (2010) 70 (8_Supplement): LB-51.

https://doi.org/10.1158/1538-7445.AM10-LB-51

Published: 15 April 2010

View article titled, Abstract LB-51: Correlation of expression of MDR-associated genes with outcome in primary ovarian serous carcinoma

Journal Articles

Evidence for Cancer Stem Cells in Human Endometrial Carcinoma

Sonya A. Hubbard, Anne M. Friel, Beena Kumar, Ling Zhang, Bo R. Rueda, Caroline E. Gargett

Cancer Res (2009) 69 (21): 8241–8248.

https://doi.org/10.1158/0008-5472.CAN-08-4808

Published: 28 October 2009

View article titled, Evidence for Cancer Stem Cells in Human Endometrial Carcinoma

Includes: Supplementary data

NARROW

Correction: Antibody–Peptide Epitope Conjugates for Personalized Cancer Therapy

Abstract 7557: Hypoxia-induced downregulation of MUC16: A key player in bispecific T-cell engager resistance in ovarian cancer

Abstract A104: Losartan rewires ovarian cancer tumor-immune microenvironment and suppresses IGF-1 to amplify chemo-immunotherapy sensitivity

Abstract A113: Extracellular vesicles derived from enriched ovarian cancer stem cell fractions promote stem like properties in the more vulnerable tumor cell populations

Abstract 5731: Apoptosis Inducing Agent 1 enhances cancer therapy-induced apoptosis by direct interaction with BAX and BAK

Abstract 2438: Loss of galectin 3 reveals its potential roles in the aggressive pathology of uterine serous carcinoma

Abstract 3390: Preliminary results for a novel single extracellular vesicle assay for early stage ovarian cancer: The power of co-localized detection of surface biomarkers

Antibody-Peptide Epitope Conjugates for Personalized Cancer Therapy

Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer

Abstract LB-229: Utilizing a novel highly specific sialyl-Tn ELISA as a diagnostic for ovarian cancer

Abstract 2504: Assessing the efficacy of the anti metabolic drug, CPI-613, for targeting of ovarian cancer stem cells

Abstract 386: Addition of mTOR inhibition to HER2 blockade results in improved antitumor activity in a preclinical model of uterine serous carcinoma with HER2 gene amplification and a gain of function mutation in PIK3CA

Abstract 3410: Inhibitors of Skp2 E3ligase stabilize nuclear p27^kip1 for regain of growth regulation in cancer.

Abstract 3285: Hedgehog pathway inhibition delays regrowth of ovarian cancer following paclitaxel and carboplatinum only if initiated immediately after completion of chemotherapy

Abstract 3474: Ovarian cancer tumor initiating cells persist after paclitaxel and carboplatinum treatment in vivo

Abstract 4556: Epidermal growth factor signaling alterations in uterine papillary serous carcinoma (UPSC) associate with survival

BRCA1-Associated Epigenetic Regulation of p73 Mediates an Effector Pathway for Chemosensitivity in Ovarian Carcinoma

Abstract 4302: Human endometrial cancer cell CD133⁺ cell fractions are regulated by methylation

Abstract LB-51: Correlation of expression of MDR-associated genes with outcome in primary ovarian serous carcinoma

Evidence for Cancer Stem Cells in Human Endometrial Carcinoma

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only